Genetic testing company Prenetics leveraged a UK-based subsidiary to buy Oxsed having piloted the latter's rapid coronavirus screening system.

Oxsed, a UK-based rapid coronavirus testing spinout of University of Oxford, was acquired for an undisclosed sum on Friday by China-headquartered genetic testing services provider Prenetics’ DNA Fit Life Sciences subsidiary. Founded in May 2020 as an impact-led enterprise, Oxsed is the creator of an RNA-driven coronavirus swab capable of results comparable to conventional lab…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.